Regulatory Updates
Sep 17, 2026•1 min read
FDA Approves ANDA076367 for Amcinonide Topical Ointment
FDA approved ANDA076367 for a 0.1% amcinonide prescription ointment; the product is currently listed as discontinued.
Regulatory Updates
Aug 30, 2026•1 min read
FDA Grants Approval for Prednisolone 5 mg Tablet (ANDA 080531) by Chartwell RX
The FDA approved application ANDA080531 for a 5 mg oral prednisolone tablet marketed by Chartwell RX, LLC, with multiple manufacturing and labeling supplements authorized.